Manchester Royal Infirmary treats first patient with breakthrough CAR-T therapy for leukaemia

manchestereveningnews.co.uk

First patient receives breakthrough 'living drug' therapy for aggressive leukaemia at Manchester Royal Infirmary. Oscar Murphy, 28, received the next-generation CAR-T therapy, a personalised treatment where a patient's own immune cells are modified to fight cancer. This advanced immunotherapy, developed by Autolus, offers hope for longer survival and potential cures for B-cell acute lymphoblastic leukaemia, with clinical trials showing high remission rates.


With a significance score of 5.8, this news ranks in the top 0.4% of today's 30534 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: